SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001213900-23-010468
Filing Date
2023-02-13
Accepted
2023-02-13 06:40:14
Documents
1
Group Members
FEI CHEN

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO SCHEDULE 13G ea173321-13ga1auspice_terns.htm SC 13G/A 58742
  Complete submission text file 0001213900-23-010468.txt   60331
Mailing Address 1065 EAST HILLSDALE BLVD., SUITE 100 FOSTER CITY CA 94404
Business Address 1065 EAST HILLSDALE BLVD., SUITE 100 FOSTER CITY CA 94404 650-525-5535 EXT.101
Terns Pharmaceuticals, Inc. (Subject) CIK: 0001831363 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-92116 | Film No.: 23614576
SIC: 2834 Pharmaceutical Preparations

Mailing Address INFINITUS TOWER 2909, 168 HUBIN ROAD HUANGPU DISTRICT SHANGHAI F4 200021
Business Address INFINITUS TOWER 2909, 168 HUBIN ROAD HUANGPU DISTRICT SHANGHAI F4 200021 86-21-23169583
Auspice Ltd (Filed by) CIK: 0001844276 (see all company filings)

IRS No.: 000000000 | State of Incorp.: F4 | Fiscal Year End: 1231
Type: SC 13G/A